Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells

  • Authors:
    • Feifei Huang
    • Yanyang Wu
    • Hong Tan
    • Tianyao Guo
    • Ke Zhang
    • Daiqiang Li
    • Zhongyi Tong
  • View Affiliations

  • Published online on: October 12, 2018     https://doi.org/10.3892/or.2018.6787
  • Pages: 590-598
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Non-small cell lung cancer (NSCLC) is one of the mostly deadly malignancies in the world. Nucleolin is a multifunctional protein that mainly regulates ribosome biogenesis but also has other functions including modulating the transcription of mRNAs and repressing RNA polymerase II. Nucleolin is overexpressed in various cancer cells, including NSCLC cells. It can confer resistance to apoptosis and promote cell migration and blood vessel formation by directly taking part in various tumor signal transduction pathways. The activities of nucleolin are regulated mainly by intracellular localization and post-translational modifications, including phosphorylation, glycosylation, methylation, and ADP-ribosylation. Phosphorylation of nucleolin (P-nucleolin) in NSCLC cells is still not well characterized. In the present study, the levels of nucleolin and P-nucleolin were examined in lung tissue and cells and it was demonstrated that levels of the two forms of nucleolin were significantly increased in NSCLC compared with non-cancerous tissues and cells. In addition, it was demonstrated that high expression levels of nucleolin and P-nucleolin were significantly associated with poor overall survival of NSCLC patients. Doxorubicin (DOX) is a type of anthracycline that has been used in the treatment of various types of cancer, including NSCLC. Upregulation of nucleolin through exogenous expression of nucleolin promoted A549 cell proliferation and migration, while downregulation of nucleolin through expression of small interfering RNA-nucleolin attenuated A549 cell proliferation and migration. Following stimulation with DOX, A549 cell proliferation and migration decreased and the expression of P-nucleolin also decreased. In order to investigate whether P-nucleolin is indispensable to the proliferation and migration of NSCLC cells, a plasmid encoding mutant nucleolin, in which the phosphorylation site at threonine-76 was mutated to alanine, was constructed. Compared with the A549 cells transfected with wild-type nucleolin, P-nucleolin expression and cell proliferation and migration were significantly decreased in A549 cells transfected with mutant nucleolin. These results indicate that targeting P-nucleolin may be a promising strategy for treating NSCLC patients.

References

1 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Smith R: Lapses at the new England journal of medicine. J R Soc Med. 99:380–382. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Park SM, Choi EY, Bae DH, Sohn HA, Kim SY and Kim YJ: The lncRNA EPEL promotes lung cancer cell proliferation through E2F target activation. Cell Physiol Biochem. 45:1270–1283. 2018. View Article : Google Scholar : PubMed/NCBI

4 

Hiddinga BI, Pauwels P, Janssens A and van Meerbeeck JP: O6-Methylguanine-DNA methyltransferase (MGMT). A drugable target in lung cancer? Lung Cancer. 107:91–99. 2017.PubMed/NCBI

5 

Xu JY, Lu S, Xu XY, Hu SL, Li B, Li WX and Chang JY: Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs. Tumour Biol. 37:10349–10356. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Zhang H, Ingham ES, Gagnon MK, Mahakian LM, Liu J, Foiret JL, Willmann JK and Ferrara KW: In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles. Biomaterials. 118:63–73. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Marcel V, Catez F, Berger CM, Perrial E, Plesa A, Thomas X, Mattei E, Hayette S, Saintigny P, Bouvet P, et al: Expression profiling of ribosome biogenesis factors reveals nucleolin as a novel potential marker to predict outcome in AML patients. PLoS One. 12:e01701602017. View Article : Google Scholar : PubMed/NCBI

8 

Berger CM, Gaume X and Bouvet P: The roles of nucleolin subcellular localization in cancer. Biochimie. 113:78–85. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Ugrinova I, Monier K, Ivaldi C, Thiry M, Storck S, Mongelard F and Bouvet P: Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. BMC Mol Biol. 8:662007. View Article : Google Scholar : PubMed/NCBI

10 

Benedetti E, Antonosante A, d'Angelo M, Cristiano L, Galzio R, Destouches D, Florio TM, Dhez AC, Astarita C, Cinque B, et al: Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model. Oncotarget. 6:42091–42104. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Gilles ME, Maione F, Cossutta M, Carpentier G, Caruana L, Di Maria S, Houppe C, Destouches D, Shchors K, Prochasson C, et al: Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature. Cancer Res. 76:7181–7193. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Wang Y, Chen J, Liang X, Han H, Wang H, Yang Y and Li Q: An ATP-Responsive Codelivery system of doxorubicin and miR-34a to synergistically inhibit cell proliferation and migration. Mol Pharm. 14:2323–2332. 2017. View Article : Google Scholar : PubMed/NCBI

13 

Mustafa EH, Mahmoud HT, Al-Hudhud MY, Abdalla MY, Ahmad IM, Yasin SR, Elkarmi AZ and Tahtamouni LH: 2-Deoxy-D-glucose synergizes with doxorubicin or L-buthionine sulfoximine to reduce adhesion and migration of breast cancer cells. Asian Pac J Cancer Prev. 16:3213–3222. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Tacar O, Sriamornsak P and Dass CR: Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 65:157–170. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Yao Y, Shen H, Zhou Y, Yang Z and Hu T: MicroRNA-215 suppresses the proliferation, migration and invasion of non-small cell lung carcinoma cells through the downregulation of matrix metalloproteinase-16 expression. Exp Ther Med. 15:3239–3246. 2018.PubMed/NCBI

16 

Xiao S, Caglar E, Maldonado P, Das D, Nadeem Z, Chi A, Trinité B, Li X and Saxena A: Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation. PLoS One. 9:e1098582014. View Article : Google Scholar : PubMed/NCBI

17 

Johansson H, Svensson F, Runnberg R, Simonsson T and Simonsson S: Phosphorylated nucleolin interacts with translationally controlled tumor protein during mitosis and with Oct4 during interphase in ES cells. PLoS One. 5:e136782010. View Article : Google Scholar : PubMed/NCBI

18 

Wu DM, Zhang P, Liu RY, Sang YX, Zhou C, Xu GC, Yang JL, Tong AP and Wang CT: Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K/Akt pathway in colorectal carcinoma. FEBS Lett. 588:1921–1929. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL, Tan C, Li XL, Shen SR, Zhou M, et al: Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol. 37:593–605. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Wang W, Wen Q, Luo J, Chu S, Chen L, Xu L, Zang H, Alnemah MM, Li J, Zhou J, et al: Suppression of β-catenin nuclear translocation by CGP57380 decelerates poor progression and potentiates radiation-induced apoptosis in nasopharyngeal carcinoma. Theranostics. 7:2134–2149. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Tong Z, Jiang B, Wu Y, Liu Y, Li Y, Gao M, Jiang Y, Lv Q and Xiao X: MiR-21 Protected cardiomyocytes against doxorubicin-induced apoptosis by targeting BTG2. Int J Mol Sci. 16:14511–14525. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Qiu W, Wang G, Sun X, Ye J, Wei F, Shi X and Lv G: The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma. Med Oncol. 32:752015. View Article : Google Scholar : PubMed/NCBI

23 

Abdelmohsen K and Gorospe M: RNA-binding protein nucleolin in disease. RNA Biol. 9:799–808. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Zhao H, Huang Y, Xue C, Chen Y, Hou X, Guo Y, Zhao L, Hu Zh, Huang Y, Luo Y, et al: Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancer. PLoS One. 8:e546742013. View Article : Google Scholar : PubMed/NCBI

25 

Qi J, Li H, Liu N, Xing Y, Zhou G, Wu Y, Liu Y, Chen W, Yue J, Han B, et al: The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas. Med Oncol. 32:452015. View Article : Google Scholar : PubMed/NCBI

26 

Cheng Y, Zhao G, Zhang S, Nigim F, Zhou G, Yu Z, Song Y, Chen Y and Li Y: AS1411-induced growth inhibition of glioma cells by up-regulation of p53 and down-regulation of Bcl-2 and Akt1 via nucleolin. PLoS One. 11:e01670942016. View Article : Google Scholar : PubMed/NCBI

27 

Dranovsky A, Vincent I, Gregori L, Schwarzman A, Colflesh D, Enghild J, Strittmatter W, Davies P and Goldgaber D: Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. Neurobiol Aging. 22:517–528. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Shang Y, Kakinuma S, Nishimura M, Kobayashi Y, Nagata K and Shimada Y: Interleukin-9 receptor gene is transcriptionally regulated by nucleolin in T-cell lymphoma cells. Mol Carcinog. 51:619–627. 2012. View Article : Google Scholar : PubMed/NCBI

29 

Wolfson E, Goldenberg M, Solomon S, Frishberg A and Pinkas-Kramarski R: Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer. Oncotarget. 7:65320–65334. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Fogal V, Sugahara KN, Ruoslahti E and Christian S: Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis. 12:91–100. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Chen SC, Hu TH, Huang CC, Kung ML, Chu TH, Yi LN, Huang ST, Chan HH, Chuang JH, Liu LF, et al: Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis. Oncotarget. 6:16253–16270. 2015.PubMed/NCBI

32 

Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, et al: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med. 210:951–968. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Jiang B, Li Y, Liang P, Liu Y, Huang X, Tong Z, Zhang P, Huang X, Liu Y and Liu Z: Nucleolin enhances the proliferation and migration of heat-denatured human dermal fibroblasts. Wound Repair Regen. 23:807–818. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Schwab MS and Dreyer C: Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin. Eur J Cell Biol. 73:287–297. 1997.PubMed/NCBI

35 

Borsig L, Wolf MJ, Roblek M, Lorentzen A and Heikenwalder M: Inflammatory chemokines and metastasis - tracing the accessory. Oncogene. 33:3217–3224. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Lin SS, Li FF, Sun L, Fan W, Gu M, Zhang LY, Qin S and Yuan ST: Marsdenia tenacissima extract suppresses A549 cell migration through regulation of CCR5-CCL5 axis, Rho C, and phosphorylated FAK. Chin J Nat Med. 14:203–209. 2016.PubMed/NCBI

37 

Choi WT, Yang Y, Xu Y and An J: Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis. Curr Top Med Chem. 14:1574–1589. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Niu H, Yang X, Xu Z, Du T and Wang R: Cell surface nucleolin interacts with CXCR4 receptor via the 212 c-terminal portion. Tumour Biol. 36:1099–1104. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

January 2019
Volume 41 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Huang, F., Wu, Y., Tan, H., Guo, T., Zhang, K., Li, D., & Tong, Z. (2019). Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells. Oncology Reports, 41, 590-598. https://doi.org/10.3892/or.2018.6787
MLA
Huang, F., Wu, Y., Tan, H., Guo, T., Zhang, K., Li, D., Tong, Z."Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells". Oncology Reports 41.1 (2019): 590-598.
Chicago
Huang, F., Wu, Y., Tan, H., Guo, T., Zhang, K., Li, D., Tong, Z."Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells". Oncology Reports 41, no. 1 (2019): 590-598. https://doi.org/10.3892/or.2018.6787